Daiichi Sankyo Co Ltd Enhertu Business Briefing Transcript
Thank you for waiting. We are now ready to start Daiichi Sankyo's Interim Business Briefing. (Operator Instructions).
Dr. Manabe. Please go ahead.
Hello, colleagues. This is Sunao Manabe, CEO of Daiichi Sankyo. Thank you very much for joining Daiichi Sankyo's ENHERTU Business Briefing during your busy end of every month's time.
Over the last several years, we have presented a lot of information and have many discussions with the investment community around ENHERTU, previously known as DS-8201. After January 2020, when we launched ENHERTU in the U.S., our presentations and discussion started to include commercial information around ENHERTU. I am very happy that now we are able to help breast cancer and gastric cancer patients with ENHERTU in multiple countries. And through that, we should set up an event for investors with a focus on the business side of ENHERTU.
Please move on to Page 3. Well, this is a slide that I presented back in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
